Methodological and Cellular Factors Affecting the Magnitude of Breast Cancer and Normal Cell Radiosensitization Using Gold Nanoparticles

• Published in: International journal of nanomedicine Vol. 18; pp. 3825 - 3850
• Main Authors: Musielak, Marika, Boś-Liedke, Agnieszka, Piwocka, Oliwia, Kowalska, Katarzyna, Markiewicz, Roksana, Lorenz, Aleksandra, Bakun, Paweł, Suchorska, Wiktoria
• Format: Journal Article
• Language: English
• Published: New Zealand Dove Medical Press Limited 01.01.2023; Dove; Dove Medical Press
• Subjects: Analysis; Breast cancer; Breast Neoplasms - pathology; Care and treatment; Cell Line, Tumor; Ethylenediaminetetraacetic acid; Female; Gold - pharmacology; Gold - therapeutic use; Humans; Metal Nanoparticles; Nanoparticles; Nanotechnology; oncology; Original Research; Radiation; Radiation-Sensitizing Agents - pharmacology; Radiation-Sensitizing Agents - therapeutic use; radiotherapy; Tumor proteins; Poland; France; Canada; nanotechnology; radiotherapy; breast cancer; nanoparticles; oncology
• ISSN: 1178-2013; 1176-9114; 1178-2013
• DOI: 10.2147/IJN.S412458

Breast cancer (BC) is the most common malignant tumor in women, which most often originates from the epithelial tissue of the breast gland. One of the most recommended kinds of treatment is radiotherapy (RT), but irradiation (IR) can affect not only the cancer tumor but also the healthy tissue around it. Au nanoparticles (AuNPs) were proposed as a radiosensitizing agent for RT which would allow for lower radiation doses, reducing the negative radiation effects on healthy tissues. The main objective of the study is to assess the dependence on the radiosensitivity of BC (MDA-MB-231) and normal mammary gland epithelial cells (MCF12A) to ionizing radiation, caused by functionalized AuNPs under diverse conditions. The viability, uptake, reactive oxygen species induction, and mitochondrial membrane potential in cells were analyzed applying a time and concentration-dependent manner. After different incubation times with AuNPs, cells were exposed to 2 Gy. The determination of radiation effect in combination with AuNPs was investigated using the clonogenic assay, p53, and γH2AX level, as well as, Annexin V staining. Our results highlighted the strong need for assessing the experimental conditions' optimization before the AuNPs will be implemented with IR. Moreover, results indicated that AuNPs did not act universally in cells. AuNPs could be a promising tool as a radiotherapy sensitizing agent, but it should be specified and deeply investigated under what conditions it will be applied taking into consideration not only AuNPs modifications but also the model and experimental conditions.